This Article
Right arrow Full Text (PDF)
Right arrow [Early Release]
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wooltorton, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wooltorton, E.
Related Collections
Right arrow Infants
Right arrow Influenza
CMAJ • February 3, 2004; 170 (3)
© 2004 Canadian Medical Association or its licensors

PRACTICE

SYNOPSIS

Health and Drug Alerts

Oseltamivir (Tamiflu) unsafe in infants under 1 year old

Eric Wooltorton

CMAJ

Reason for posting: Influenza is a common and potentially serious infection in children. Neuraminidase inhibitors are sometimes used to treat and prevent the disease in some children. However, the US Food and Drug Administration (FDA) recently warned that studies involving juvenile rats showed potential toxicity of oseltamivir for human infants less than a year old (www.fda.gov/medwatch/SAFETY/2003/safety03.htm#tamiflu).

The drug: Oseltamivir (Tamiflu) inhibits the influenza neuraminidase enzyme, thus preventing the release and dispersion of budding viruses. In Canada the drug can be used to treat influenza in children older than 1 year with symptoms of less than 2 days' duration and to prevent the disease in children over 13 years old.

The unpublished trial described by the FDA involved 7-day-old rats being fed a single dose of 1000 mg/kg of oseltamivir — about 250 times the dose recommended for children. The treatment was toxic, often killing the animals, and brain levels of the drug were 1500 times those of adult animals exposed to the same dose. It is hypothesized that an immature blood–brain barrier may cause the toxicity.

What to do: Oseltamivir should not be given to children less than a year old. Basic infection control precautions such as keeping the child away from sick people, frequent handwashing and flu shots (for children over 6 months old and caregivers) may be the best way to prevent the disease. The relative safety profile of other antiviral agents (amantadine, zanamivir) in the very young pediatric population is unclear. — Eric Wooltorton, CMAJ




This article has been cited by other articles:


Home page
 Hum Exp ToxicolHome page
Y Izumi, K Tokuda, K. O'Dell, C. Zorumski, and T Narahashi
Synaptic and behavioral interactions of oseltamivir (Tamiflu) with neurostimulants
Human and Experimental Toxicology, December 1, 2008; 27(12): 911 - 917.
[Abstract] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
D. Shi, J. Yang, D. Yang, E. L. LeCluyse, C. Black, L. You, F. Akhlaghi, and B. Yan
Anti-Influenza Prodrug Oseltamivir Is Activated by Carboxylesterase Human Carboxylesterase 1, and the Activation Is Inhibited by Antiplatelet Agent Clopidogrel
J. Pharmacol. Exp. Ther., December 1, 2006; 319(3): 1477 - 1484.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Full Text (PDF)
Right arrow [Early Release]
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wooltorton, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wooltorton, E.
Related Collections
Right arrow Infants
Right arrow Influenza